Security Forces tasked with defending Minuteman III ICBMs currently train for everything from retaking captured silos to repelling ground assaults.
CUMBRIA Fire and Rescue Service will be running 'Biker Down' sessions to teach life-saving skills to the public.
With the new film "MELANIA" posting the best opening weekend for a documentary in over a decade, the first lady revealed the challenges of making the film as well as details about her role as she ...
The alarm bells sounded for days leading up to the big whiteout of ’26. We all knew it was coming, but somehow no one was prepared. Snow mountains soared, some as high as a foot and a half. There were ...
I attended my very first red carpet premiere and got a behind-the-scenes look at what it’s really like, from arriving at the venue to experiencing the excitement of premiere night. #redcarpet ...
For those who may not already know, “Heated Rivalry” is Jacob Tierney’s six-episode adaptation of Rachel Reid’s queer hockey romance novel series “Game Changers.” The show, acquired for U.S.
If you weren’t already invested in the Miami Dolphins’ 2026 NFL draft strategy, then let their blowout loss to the Cincinnati Bengals serve as a wake-up call. The Dolphins have a lot of needs to fill ...
Sex scenes are way more technical than they look. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. I was less exposed than Hudson was, right? I’m ...
CREATE Medicines Doses First Patient in Frontline HCC Trial Evaluating MT-303, an In Vivo CAR Therapy, in Combination with Standard-of-Care Immunotherapy By CREATE Medicines, Inc. Dec 9, 2025 Updated ...
“The decision to evaluate visugromab in second-line nsq NSCLC, in addition to the first-line setting, was driven by the strength of our Phase 1/2a data in heavily pretreated patients, where we ...
The Miami Dolphins got two key starters back from injury in their Week 13 win against the New Orleans Saints, and one of them required quite a bit of patience. Right tackle Austin Jackson returned to ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that the first participant has been enrolled in the BLOOM Phase 2 ...